Top

Published in:

26-09-2022 | Multiple Sclerosis | Original Research Article

Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis

Authors: I. Kleerekooper, L. Del Porto, L. Dell’Arti, J. Guajardo, S. Leo, A. G. Robson, S. A. Trip, A. Petzold, G. T. Plant, G. E. Holder

Published in: Documenta Ophthalmologica | Issue 3/2022

Abstract

Purpose

Macular involvement in optic neuritis (ON) is well-recognised but poorly understood and may be of clinical relevance. This study explores macular structure–function correlates in acute ON.

Methods

This cross-sectional cohort study recruited ON patients within 14 days of symptom onset. Subjects underwent pattern electroretinography (PERG), pattern visual evoked potentials (PVEP) and optical coherence tomography (OCT) imaging. PERG P50 and N95 components were correlated with OCT data.

Results

Twenty-six individuals with ON were recruited, comprising eleven multiple sclerosis (MS-ON), six myelin oligodendrocyte glycoprotein associated (MOG-ON) and nine with isolated ON. These were compared with 28 healthy controls. PVEPs were undetectable in 11 (42%) of individuals with ON. When detectable, PVEP P100 was delayed (median 136 ms range 110–173 ms) and amplitude reduced (median 6 μV, range 3–14 μV) in ON compared with controls (both p < 0.001). PERG P50 component amplitudes, largely reflecting macular function, were reduced in affected eyes (median 2.3 μV; range 0.8–5.0 μV) compared with controls (3.3 μV; range 2.8–5.7 μV) and compared with fellow eyes (p < 0.001). The N95:P50 ratio was below the reference range in the affected eyes of five patients. Eight cases (32%) had subnormal P50 amplitudes (< 2.0 μV), and these patients had poorer visual acuity (p = 0.020). P50 amplitudes were positively correlated with an increase in inner nuclear layer thickness (r_s = 0.36; p = 0.009) and macular ganglion cell and inner plexiform layer (mGCIPL) thickness (r_s = 0.44, p = 0.022).

Conclusion

PERG P50 component reduction reveals dysfunction of inner macular layers in acute ON and correlates with structural alterations on OCT. These early macular pathologic processes are likely to contribute to the visual loss.

Available only for authorised users

Petzold A, Wattjes MP, Costello F et al (2014) The investigation of acute optic neuritis: a review and proposed protocol. Nat Rev Neurol 10:447–458. https://doi.org/10.1038/nrneurol.2014.108

Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83–99. https://doi.org/10.1016/S1474-4422(13)70259-X

Kaufhold F, Zimmermann H, Schneider E et al (2013) Optic neuritis is associated with inner nuclear layer thickening and microcystic macular edema independently of multiple sclerosis. PLoS ONE. https://doi.org/10.1371/journal.pone.0071145CrossRefPubMedPubMedCentral

Balk LJ, Coric D, Knier B et al (2019) Retinal inner nuclear layer volume reflects inflammatory disease activity in multiple sclerosis; a longitudinal OCT study. Mult Scler J Exp Transl Clin 5:205521731987158. https://doi.org/10.1177/2055217319871582CrossRef

Lightman S, Mcdonald WI, Bird AC et al (1987) Retinal venous sheathing in optic neuritis: Its significance for the pathogenesis of multiple sclerosis. Brain 110:405–414. https://doi.org/10.1093/brain/110.2.405CrossRefPubMed

Messenger W, Hildebrandt L, Mackensen F et al (2015) Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol 99:205–209. https://doi.org/10.1136/bjophthalmol-2014-305518CrossRefPubMed

Green AJ, McQuaid S, Hauser SL et al (2010) Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration. Brain 133:1591–1601. https://doi.org/10.1093/brain/awq080CrossRefPubMedPubMedCentral

Gelfand JM, Cree BA, Nolan R et al (2013) Microcystic inner nuclear layer abnormalities and neuromyelitis optica. JAMA Neurol 70:629–633. https://doi.org/10.1001/jamaneurol.2013.1832CrossRefPubMed

Abegg M, Dysli M, Wolf S et al (2014) Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology 121:142–149. https://doi.org/10.1016/j.ophtha.2013.08.045CrossRefPubMed

10.

Kaushik M, Wang CY, Barnett MH et al (2013) Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis. PLoS ONE 8:4–11. https://doi.org/10.1371/journal.pone.0078341CrossRef

11.

Knier B, Schmidt P, Aly L et al (2016) Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis. Brain 139:2855–2863. https://doi.org/10.1093/brain/aww219CrossRefPubMed

12.

Holder GE (1987) Significance of abnormal pattern electroretinography in anterior visual pathway dysfunction. Br J Ophthalmol 71:166–171. https://doi.org/10.1136/bjo.71.3.166CrossRefPubMedPubMedCentral

13.

Viswanathan S, Frishman LJ, Robson JG (2000) The uniform field and pattern ERG in macaques with experimental glaucoma: removal of spiking activity. Investig Ophthalmol Vis Sci 41:2797–2810

14.

Holder GE (1991) The incidence of abnormal pattern electroretinography in optic nerve demyelination. Electroencephalogr Clin Neurophysiol 78:18–26. https://doi.org/10.1016/0013-4694(91)90014-UCrossRefPubMed

15.

Plant GT, Hess RF, Thomas SJ (1986) The pattern evoked electroretinogram in optic neuritis: a combined psychophysical and electrophysiological study. Brain 109:469–489. https://doi.org/10.1093/brain/109.3.469CrossRefPubMed

16.

Holder GE (2001) Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis. Prog Retin Eye Res 20:531–561. https://doi.org/10.1016/S1350-9462(00)00030-6CrossRefPubMed

17.

Berninger TA, Heider W (1990) Pattern electroretinograms in optic neuritis during the acute stage and after remission. Graefe’s Arch Clin Exp Ophthalmol 228:410–414CrossRef

18.

Odom JV, Bach M, Brigell M et al (2016) ISCEV standard for clinical visual evoked potentials: (2016 update). Doc Ophthalmol. https://doi.org/10.1007/s10633-016-9553-yCrossRefPubMed

19.

Tewarie P, Balk L, Costello F et al (2012) The OSCAR-IB consensus criteria for retinal OCT quality assessment. PLoS ONE 7:1–7. https://doi.org/10.1371/journal.pone.0034823CrossRef

20.

Holder GE (1989) Pattern electroretinography in patients with delayed pattern visual evoked potentials due to distal anterior visual pathway dysfunction. J Neurol Neurosurg Psychiatry 52:1364–1368. https://doi.org/10.1136/jnnp.52.12.1364CrossRefPubMedPubMedCentral

21.

Holder GE (2004) Electrophysiological assessment of optic nerve disease. Eye 18:1133–1143. https://doi.org/10.1038/sj.eye.6701573CrossRefPubMed

22.

Halliday AM, Mcdonald WI, Mushin J (1972) Delayed visual evoked response in optic neuritis. Lancet 299:982–985. https://doi.org/10.1016/S0140-6736(72)91155-5CrossRef

23.

Hokazono K, Raza AS, Oyamada MK et al (2013) Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry. Doc Ophthalmol 127:201–215. https://doi.org/10.1007/s10633-013-9401-2CrossRefPubMed

24.

Parisi V (2003) Correlation between morphological and functional retinal impairment in patients affected by ocular hypertension, glaucoma, demyelinating optic neuritis and Alzheimer’s disease. Semin Ophthalmol 18:50–57. https://doi.org/10.1076/soph.18.2.50.15855CrossRefPubMed

25.

Al-Nosairy KO, Horbrügger M, Schippling S et al (2021) Structure-function relationship of retinal ganglion cells in multiple sclerosis. Int J Mol Sci 22:1–14. https://doi.org/10.3390/ijms22073419CrossRef

26.

Holder GE (1997) The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes. Eye 11:924–934. https://doi.org/10.1038/eye.1997.231CrossRefPubMed

27.

Monsalve P, Ren S, Jiang H et al (2018) Retinal ganglion cell function in recovered optic neuritis: faster is not better. Clin Neurophysiol 129:1813–1818. https://doi.org/10.1016/j.clinph.2018.06.012CrossRefPubMed

28.

Wang M, Guo H, Li S et al (2020) Electrophysiological and structural changes in Chinese patients with LHON. J Ophthalmol. https://doi.org/10.1155/2020/4734276CrossRefPubMedPubMedCentral

29.

Holder G, Votruba M, Carter A et al (1999) Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter. Doc Ophthalmol 95:217–228CrossRef

30.

Mauguiere F, Holder G, Luxon L et al (1995) Abnormal waveforms and diagnostic yield of evoked potentials. In: Osselton J, Binnie C, Cooper R et al (eds) Clinical neurophysiology: EMG; nerve conduction and evoked potentials. Butterworth-Heinemann, Oxford, pp 431–481

31.

Saidha S, Syc SSB, Ibrahim MMA et al (2011) Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain 134:518–533. https://doi.org/10.1093/brain/awq346CrossRefPubMed

32.

Balk LJ, Twisk JWR, Steenwijk MD et al (2014) A dam for retrograde axonal degeneration in multiple sclerosis? J Neurol Neurosurg Psychiatry 85:782–789. https://doi.org/10.1136/jnnp-2013-306902CrossRefPubMed

33.

Rucker C (1945) Sheathing of the retinal veins in multiple sclerosis. JAMA 127:970–973. https://doi.org/10.1001/jama.1945.02860150014003CrossRef

34.

Davies AL, Desai RA, Bloomfield PS et al (2013) Neurological deficits caused by tissue hypoxia in neuroinflammatory disease. Ann Neurol 74:815–825. https://doi.org/10.1002/ana.24006CrossRefPubMed

Title: Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis
Authors: I. Kleerekooper
L. Del Porto
L. Dell’Arti
J. Guajardo
S. Leo
A. G. Robson
S. A. Trip
A. Petzold
G. T. Plant
G. E. Holder
Publication date: 26-09-2022
Publisher: Springer Berlin Heidelberg
Keywords: Multiple Sclerosis
Evoked Potential
Optic Neuritis
Evoked Potential
Published in: Documenta Ophthalmologica / Issue 3/2022
Print ISSN: 0012-4486
Electronic ISSN: 1573-2622
DOI: https://doi.org/10.1007/s10633-022-09896-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Pattern ERGs suggest a possible retinal contribution to the visual acuity loss in acute optic neuritis

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2022

Melanoma-associated retinopathy with anti-TRPM1 autoantibodies showing concomitant Off-bipolar cell dysfunction

Two cases of unilateral cone–rod dysfunction presenting in adult females

Safety of intravitreal metoprolol in eyes with central serous chorioretinopathy

Flicker electroretinogram in newborn infants

Fullfield and extrafoveal visual evoked potentials in healthy eyes: reference data for a curved OLED display

Residual rod function in CNGB1 mutant dogs